Free account + included starter software — credential review typically takes 1–2 business days. See how it works
NDC 68462-0157-13

Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING

Glenmark Pharmaceuticals Inc., USA

In Stock at Premier Pharma
NDC
68462-0157-13
Generic Name
Ondansetron
Brand Name
Ondansetron
Strength
4 mg/1
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Package Size
Labeler
Glenmark Pharmaceuticals Inc., USA

FDA Drug Information

Indications & Usage

1 INDICATIONS AND USAGE Ondansetron is indicated for the prevention of nausea and vomiting associated with: • highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 • initial and repeat courses of moderately emetogenic cancer chemotherapy • radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen Ondansetron is also indicated for the prevention of postoperative nausea and/o…

Source: FDA. For professional use only. Not a substitute for prescribing information.

Order NDC 68462-0157-13 at Wholesale

Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).